Ceforanide
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | Intramuscular |
ATC code | |
Pharmacokinetic data | |
Protein binding | 80.6% |
Metabolism | Nil |
Biological half-life | 2.6 to 2.98 hours |
Excretion | Renal |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
NIAID ChemDB | |
Chemical and physical data | |
Formula | C20H21N7O6S2 |
Molar mass | 519.556 g/mol |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Ceforanide is a second-generation cephalosporin antibiotic.
See also
External links
- Crowle A, Sbarbaro J, May M (1988). "Effects of isoniazid and of ceforanide against virulent tubercle bacilli in cultured human macrophages.". Tubercle. 69 (1): 15–25. PMID 3140456. doi:10.1016/0041-3879(88)90036-0.
- Campoli-Richards D, Lackner T, Monk J (1987). "Ceforanide. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.". Drugs. 34 (4): 411–37. PMID 3315624. doi:10.2165/00003495-198734040-00001.
- Cone L, Barton S, Woodard D (1987). "Treatment of scleroma with ceforanide.". Arch Otolaryngol Head Neck Surg. 113 (4): 374–6. PMID 3814386. doi:10.1001/archotol.1987.01860040036012.
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.